Trademarkia Logo

Canada

C$
VISISURE & DESIGN
REGISTERED

on 17 Nov 2020

Last Applicant/ Owned by

NOVARTIS AG

4002 Basel

CH

Serial Number

1941003 filed on 16th Jan 2019

Registration Number

TMA1087769 registered on 17th Nov 2020

Registration expiry Date

17th Nov 2030

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

VISISURE & DESIGN

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Vienna Information


24 . 17 . 20

Check signsCoches, signes de validation

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 15

Letters or numerals representing an objectLettres ou chiffres représentant un objet

29 . 1 . 4

BlueBleu

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, systemic and topical anti-fungals


Classification kind code

11

Class [010]
A medical instrument for the injection of drugs for human use, namely, syringes for injections, injection kits comprising syringes for injections and needles for injections


Classification kind code

11

Mark Details


Serial Number

1941003

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 28th Oct 2020
Registration Pending
Submitted for opposition 42
on 5th Aug 2020
Advertised
Submitted for opposition 26
on 13th Jul 2020
Approved
Submitted for opposition 27
on 13th Jul 2020
Approval Notice Sent
Submitted for opposition 22
on 23rd Oct 2019
Search Recorded
Submitted for opposition 20
on 23rd Oct 2019
Examiner's First Report
Submitted for opposition 67
on 11th Sept 2019
Agent Name Changed
Submitted for opposition 31
on 21st Jan 2019
Formalized
Submitted for opposition 30
on 16th Jan 2019
Filed
Submitted for opposition 1
on 16th Jan 2019
Created